Frankfurt - Delayed Quote EUR
Serina Therapeutics Inc. R (2BO.F)
5.10
+0.50
+(10.87%)
At close: 3:29:01 PM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 6.4M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| JUVENESCENCE LTD. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 4.55 - 4.70 per share. | Indirect | 4,625,000 | Jan 31, 2025 |
| BAILEY GREGORY HUGH Director | Purchase at price 4.59 per share. | Direct | 17,745 | Dec 17, 2024 |
| BAILEY GREGORY HUGH Director | Purchase at price 6.03 per share. | Direct | 6,851 | Sep 20, 2024 |
| BAILEY GREGORY HUGH Director | Purchase at price 6.11 - 6.23 per share. | Direct | 88,257 | Sep 19, 2024 |
| MINTZ STEVEN MICHAEL Director | Purchase at price 6.47 per share. | Indirect | 38,814 | Sep 12, 2024 |
| BAILEY GREGORY HUGH Director | Purchase at price 8.25 per share. | Direct | 14,652 | Aug 20, 2024 |
| BAILEY GREGORY HUGH Director | Purchase at price 6.65 - 7.93 per share. | Direct | 140,116 | Aug 19, 2024 |
| MINTZ STEVEN MICHAEL Director | Purchase at price 6.59 per share. | Indirect | 58,928 | Aug 15, 2024 |
| BAILEY GREGORY HUGH Director | Purchase at price 7.07 per share. | Direct | 45,228 | Aug 14, 2024 |
| MINTZ STEVEN MICHAEL Director | Purchase at price 9.00 - 9.50 per share. | Direct | 70,900 | Jun 25, 2024 |
| JUVENESCENCE LTD. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 13.20 per share. | Indirect | 4,987,818 | Jun 6, 2024 |
| BAILEY GREGORY HUGH Director | Purchase at price 9.50 per share. | Direct | 60,591 | May 30, 2024 |
| BAILEY GREGORY HUGH Director | Purchase at price 9.50 per share. | Direct | 85,680 | May 28, 2024 |
| BAILEY GREGORY HUGH Director | Purchase at price 9.50 per share. | Direct | 31,226 | May 23, 2024 |
| BAILEY GREGORY HUGH Director | Purchase at price 9.50 per share. | Direct | 13,509 | May 21, 2024 |
| MINTZ STEVEN MICHAEL Director | Purchase at price 8.50 - 10.00 per share. | Indirect | 120,827 | May 21, 2024 |
| BAILEY GREGORY HUGH Director | Purchase at price 9.00 per share. | Direct | 900 | May 20, 2024 |
Related Tickers
ZA71.F Larimar Therapeutics, Inc.
1.9400
-6.73%
2GH.F Merus N.V.
32.60
-10.44%
PCJ.F Abeona Therapeutics Inc.
4.5000
-2.17%
DRUG.CN Bright Minds Biosciences Inc.
47.48
0.00%
NEXI NexImmune, Inc.
0.0001
0.00%
VALN Valneva SE
6.99
+1.75%
SION Sionna Therapeutics, Inc.
12.60
-3.74%
AARD Aardvark Therapeutics, Inc. Common Stock
8.22
-3.52%
KALV KalVista Pharmaceuticals, Inc.
12.88
+3.45%
ADVM Adverum Biotechnologies, Inc.
2.9700
+4.21%